Gislaine Fraboulet
Cergy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Journal: Cancer management and research
Published: June 19, 2019
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study).
Journal: Oncotarget
Published: September 22, 2017
Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
Journal: Bulletin du cancer
Published: June 06, 2017
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 29, 2014
Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 16, 2014
Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).
Journal: Journal of geriatric oncology
Published: May 23, 2014
Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026